Citadel Advisors’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-36,300
| Closed | -$376K | – | 14241 |
|
|
2022
Q2 | $376K | Buy |
36,300
+1,800
| +5% | +$13.4K | ﹤0.01% | 9286 |
|
|
2022
Q1 | $305K | Sell |
34,500
-8,900
| -21% | -$67.5K | ﹤0.01% | 10560 |
|
|
2021
Q4 | $300K | Buy |
43,400
+30,200
| +229% | +$443K | ﹤0.01% | 10929 |
|
|
2021
Q3 | $164K | Sell |
13,200
-66,500
| -83% | -$959K | ﹤0.01% | 12258 |
|
|
2021
Q2 | $1.45M | Buy |
+79,700
| New | +$1.58M | ﹤0.01% | 7390 |
|
|
2021
Q1 | – | Sell |
-31,100
| Closed | -$555K | – | 13939 |
|
|
2020
Q4 | $555K | Buy |
31,100
+18,600
| +149% | +$279K | ﹤0.01% | 7946 |
|
|
2020
Q3 | $142K | Sell |
12,500
-1,600
| -11% | -$19.8K | ﹤0.01% | 9042 |
|
|
2020
Q2 | $192K | Sell |
14,100
-34,400
| -71% | -$474K | ﹤0.01% | 8564 |
|
|
2020
Q1 | $631K | Sell |
48,500
-15,200
| -24% | -$271K | ﹤0.01% | 6108 |
|
|
2019
Q4 | $1.28M | Buy |
63,700
+17,800
| +39% | +$432K | ﹤0.01% | 5146 |
|
|
2019
Q3 | $1.18M | Buy |
45,900
+8,400
| +22% | +$206K | ﹤0.01% | 5297 |
|
|
2019
Q2 | $914K | Buy |
37,500
+600
| +2% | +$13.1K | ﹤0.01% | 5833 |
|
|
2019
Q1 | $736K | Sell |
36,900
-25,000
| -40% | -$456K | ﹤0.01% | 6131 |
|
|
2018
Q4 | $1.02M | Sell |
61,900
-5,800
| -9% | -$97.7K | ﹤0.01% | 5275 |
|
|
2018
Q3 | $1.21M | Buy |
67,700
+38,600
| +133% | +$873K | ﹤0.01% | 5223 |
|
|
2018
Q2 | $858K | Buy |
29,100
+5,700
| +24% | +$180K | ﹤0.01% | 5482 |
|
|
2018
Q1 | $841K | Sell |
23,400
-122,000
| -84% | -$4.41M | ﹤0.01% | 5065 |
|
|
2017
Q4 | $4.62M | Buy |
145,400
+116,700
| +407% | +$3.66M | ﹤0.01% | 2562 |
|
|
2017
Q3 | $1.11M | Buy |
28,700
+11,400
| +66% | +$448K | ﹤0.01% | 4175 |
|
|
2017
Q2 | $782K | Buy |
17,300
+3,500
| +25% | +$134K | ﹤0.01% | 4465 |
|
|
2017
Q1 | $533K | Sell |
13,800
-5,500
| -28% | -$231K | ﹤0.01% | 4910 |
|
|
2016
Q4 | $734K | Buy |
19,300
+5,600
| +41% | +$266K | ﹤0.01% | 4314 |
|
|
2016
Q3 | $741K | Buy |
13,700
+7,400
| +117% | +$376K | ﹤0.01% | 4248 |
|
|
2016
Q2 | $232K | Sell |
6,300
-10,300
| -62% | -$364K | ﹤0.01% | 5611 |
|
|
2016
Q1 | $522K | Sell |
16,600
-100
| -0.6% | -$3.46K | ﹤0.01% | 4360 |
|
|
2015
Q4 | $1.03M | Sell |
16,700
-4,100
| -20% | -$259K | ﹤0.01% | 3529 |
|
|
2015
Q3 | $1.44M | Buy |
20,800
+10,300
| +98% | +$715K | ﹤0.01% | 3344 |
|
|
2015
Q2 | $711K | Buy |
10,500
+10,400
| +10,400% | +$484K | ﹤0.01% | 4452 |
|
|
2015
Q1 | $4K | Buy |
+100
| New | +$4.49K | ﹤0.01% | 8364 |
|
Other funds holding RDUS
Citadel Advisors's RDUS Position: Q3 2022 in Review
Citadel Advisors sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 270,747 shares — an estimated $2.81M sold.
Citadel Advisors first reported a position in RDUS in Q2 2014 and held it in 32 quarters. The position peaked at $63.4M in Q3 2015. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- Citadel Advisors reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- Citadel Advisors sold 270,747 Radius Health, Inc. shares in Q3 2022, an estimated $2.81M.
- Citadel Advisors first reported a position in Radius Health, Inc. in Q2 2014 and held it in 32 quarters.
- Citadel Advisors's Radius Health, Inc. position peaked at $63.4M in Q3 2015.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.